FDA Inspection 1339108 — Litex Manufacturing, Inc
The FDA completed an inspection of Litex Manufacturing, Inc on Oct 2, 2026 in Glendale, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). 3 citations were issued during this inspection. Product area: Devices.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Oct 2, 2026
- Fiscal Year
- 2027
- Product Type
- Devices
- Project Area
- Postmarket Assurance: Devices
- Location
- Glendale, CA (United States)
Citations
| ID | CFR | Description |
|---|---|---|
| 23101 | ISO 13485:2016 Clause 7.3.2 | Design and development planning documentation not adequate |
| 23169 | ISO 13485:2016 Clause 7.5.6 | Procedures for validation of processes not documented |
| 23230 | ISO 13485:2016 Clause 8.2.6 | Monitoring and measurement requirements of product characteristics are not met |